Sponsors (13)
The bill prioritizes federal support and coordination for quantum-enabled molecular modeling to accelerate scientific and industrial innovation (drugs, materials, energy, defense), but does so amid limited new funding and dual-use risks, shifting resources and raising ethical and equity concerns.
Scientists and researchers gain formal federal recognition of 'quantum molecular modeling or simulation' plus improved tools and interagency coordination, enabling faster, more accurate simulations that accelerate discovery in medicine, materials, and energy.
Patients (including those with chronic conditions) could see safer, more effective drugs as simulation capabilities reduce harmful interactions and speed drug design.
Energy users and manufacturers may benefit from improved batteries, energy storage, and related materials innovations that lower costs and improve performance for businesses and consumers.
Scientists and federal research programs may face new expectations without additional funding, and attention or funds could be shifted away from other research priorities, imposing opportunity costs on taxpayers and researchers.
Improved simulation capabilities and a research focus on quantum-enabled military or law-enforcement gear raise dual-use and ethical risks—potential misuse, escalation, and civilian harm.
Commercialization of advanced materials and drugs could concentrate benefits among well-capitalized firms, limiting near-term price relief for consumers and disadvantaging smaller businesses.
Based on analysis of 6 sections of legislative text.
Adds "quantum molecular modeling or simulation" to the National Quantum Initiative's statutory list of quantum research priorities without providing new funding.
Introduced March 2, 2026 by Randy Feenstra · Last progress March 2, 2026
Adds “quantum molecular modeling or simulation” to the federal research priorities for quantum information science, formally expanding the kinds of quantum research singled out for attention under the National Quantum Initiative framework. The change is limited to the statutory definition and does not create new funding, deadlines, or agencies.